Mira Alsheikh

Mira Alsheikh practices at Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health.

Mira Alsheikh's NPI, 1932620358, was assigned on July 6, 2017. Mira Alsheikh holds Maine license MD26392.

Mira Alsheikh's primary practice is Northern Light Eastern Maine Medical Center, at 489 State Street, Bangor, ME 04401 in Penobscot County. The practice phone is (207) 973-7000.

Mira Alsheikh's primary practice is Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health. Mira Alsheikh is also affiliated with Northern Light Maine Coast Hospital. The medical group on file is Northern Light Eastern Maine Medical Center. Dmand AI also links Mira Alsheikh to 1 more hospital and 1 breast imaging center, each named with a free account. Mira Alsheikh's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Mira Alsheikh practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Mira Alsheikh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Mira Alsheikh is licensed in Maine.

CMS data shows 403 Medicare services from Mira Alsheikh across 12 procedure codes in 2024, for 277 Medicare patients. Medicare paid $31,549 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Mira Alsheikh in 2024. The largest group is 65 to 74, with 108 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mira Alsheikh's median patient age at 60, with 59% women.

In 2024, Mira Alsheikh wrote 364 Medicare Part D claims for 126 patients. 70% of them were for generic drugs. CMS names the drug for 217 of them, across 10 drugs with 11 or more claims each, at $129,144 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Mira Alsheikh for performance year 2024, reported through an alternative payment model (APM). Mira Alsheikh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 108 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Mira Alsheikh, more than 78% of the clinicians it reports for that procedure.

CMS Open Payments shows 8 general payments to Mira Alsheikh from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 97% of the total. Sanofi and Genzyme US Companies paid the most, $253.